Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn ’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
In the original publication of this article, the following correction should be noted in Table 5.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Arthritis | Crohn's Disease | Drugs & Pharmacology | Psoriasis | Psoriatic Arthritis | Rheumatology | Stelara